Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nymox Pharm Corp (NYMX)

Nymox Pharm Corp (NYMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,103
  • Shares Outstanding, K 90,515
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,580 K
  • 60-Month Beta 0.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NYMX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.02 on 05/12/23
  • Latest Earnings Date 08/21/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1688 +18.48%
on 06/30/23
0.4170 -52.04%
on 06/16/23
-0.2077 (-50.94%)
since 06/06/23
3-Month
0.1688 +18.48%
on 06/30/23
0.4950 -59.60%
on 05/08/23
-0.1559 (-43.80%)
since 04/06/23
52-Week
0.1688 +18.48%
on 06/30/23
0.7427 -73.07%
on 12/08/22
-0.2000 (-50.00%)
since 07/06/22

Most Recent Stories

More News
Nymox: Q3 Earnings Snapshot

Nymox: Q3 Earnings Snapshot

NYMX : 0.2000 (-19.68%)
Nymox: Q2 Earnings Snapshot

Nymox: Q2 Earnings Snapshot

NYMX : 0.2000 (-19.68%)
NYMOX Updates Shareholders

IRVINE, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced an update to its shareholders regarding...

NYMX : 0.2000 (-19.68%)
NYMOX Receives Deficiency Letter from NASDAQ

IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports that on July 7, 2022 the Company received a...

NYMX : 0.2000 (-19.68%)
NYMOX Receives RTF letter from FDA

IRVINE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports today that it has received a Refusal to File...

NYMX : 0.2000 (-19.68%)
Nymox Announces Closing of $6.4 Million Financing

IRVINE, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has...

NYMX : 0.2000 (-19.68%)
Nymox Announces $5 Million Registered Direct Offering

IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive...

NYMX : 0.2000 (-19.68%)
NYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate

IRVINE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce today that it...

NYMX : 0.2000 (-19.68%)
Nymox Shareholder Update

HASBROUCK HEIGHTS, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it...

NYMX : 0.2000 (-19.68%)
NYMOX Presenting at Torrey Hills Capital Emerging Growth Conference

NYMOX Provides Current Update...

NYMX : 0.2000 (-19.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Nymox Pharmaceutical Corporation is engaged in the research and development of drugs and diagnostic products. The company offers products such as AlzheimAlert, NicAlert and TobacAlert tests. It markets its products primarily in the United States, Canada, and Europe. Nymox Pharmaceutical Corporation is...

See More

Key Turning Points

3rd Resistance Point 0.2564
2nd Resistance Point 0.2382
1st Resistance Point 0.2191
Last Price 0.2000
1st Support Level 0.1818
2nd Support Level 0.1636
3rd Support Level 0.1445

See More

52-Week High 0.7427
Fibonacci 61.8% 0.5235
Fibonacci 50% 0.4557
Fibonacci 38.2% 0.3880
Last Price 0.2000
52-Week Low 0.1688

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar